Kitov Pharmaceuticals Hldgs L Sponsored ADR (KTOV)

[ash111]

KTOV My advice to you,

Cherry picking information can cause you a big burn. Watch us making big Money when NDA hits. https://www.streetinsider.com/dr/news.php?id=12074650

Backup with patent affords up to 13 years of protection within the US while EU market.
NSAID - pain relief drug with its
“black box”, warning of the risk of
heart attack, stroke, and death

KIT-302 - with labeling noting
reduction of blood pressure and
lowering the risk of heart attack,
stroke and death

Once approved, KIT-302 will be the only drug in the market able to claim simultaneous treatment of OA pain and treatment of hypertension.

World-wide sales of Celebrex® alone were $2.7 billion in 2014, ~$1B in 2015 (due to generic competition).

A/o today market cap is $15m equal to Cash on hand. Kitov also has 53% ownership on another Company holds a breakthrough patent. Big undervalued if you ask me.